4//SEC Filing
Hadfield Robert 4
Accession 0001209191-20-005783
CIK 0001107421other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:48 PM ET
Size
7.2 KB
Accession
0001209191-20-005783
Insider Transaction Report
Form 4
Hadfield Robert
General Counsel and Secretary
Transactions
- Award
Common Stock
2020-01-29+59,100→ 159,819 total - Award
Employee Stock Option (right to buy)
2020-01-29+90,800→ 90,800 totalExercise: $4.21Exp: 2030-01-29→ Common Stock (90,800 underlying)
Footnotes (2)
- [F1]19,700 shares shall vest on each of 12/31/2020, 12/31/2021 and 12/31/2022.
- [F2]1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2019.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001630687
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:48 PM ET
- Size
- 7.2 KB